BN 80933Alternative Names: BIM 80933; BN80933
Latest Information Update: 30 Nov 2010
At a glance
- Originator Institut Henri Beaufour-Ipsen
- Class Anti-ischaemics; Antiparkinsonians; Neuroprotectants; Pyrazines; Small molecules; Thiophenes
- Mechanism of Action Free radical scavengers; Lipid peroxidation inhibitors; Nitric oxide synthase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cerebral ischaemia; Neurological disorders